EMAZOLE

This brand name is authorized in Ireland, Malta, Singapore.

Active ingredients

The drug EMAZOLE contains one active pharmaceutical ingredient (API):

1	Esomeprazole UNII L2C9GWQ43H - ESOMEPRAZOLE SODIUM
	Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+ K+ -ATPase – the acid pump and inhibits both basal and stimulated acid secretion.
	Read more about Esomeprazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EMAZOLE Gastro-resistant tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC05	Esomeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
IE	Health Products Regulatory Authority	36506, 36507
MT	Medicines Authority	AA1122/00401, AA1122/00402, AA1316/00701, AA1316/00702, AA1454/00101, AA908/19101, AA908/19102, AA908/19103
SG	Health Sciences Authority	15500P